Literature DB >> 18641726

Exercise and the fatty liver.

Natasha A Spassiani1, Jennifer L Kuk.   

Abstract

Fatty liver is an increasingly prevalent condition that is associated with several metabolic derangements, thus necessitating the development of effective therapeutic interventions. Growing evidence from cross-sectional studies suggest that physical activity may be a promising therapy for fatty liver. Unfortunately, longitudinal evidence supporting this observation in humans is sparse, as the majority of intervention studies have examined the relationship between liver fat and physical activity in conjunction with caloric and dietary fat restriction. Studies in rats demonstrate a beneficial effect of exercise on liver fat, mainly in situations of high fat feeding or obesity. Thus, the independent contribution of physical activity on variations in liver fat is unknown, but remains a promising intervention that requires further investigation. There is some evidence to suggest that both physical activity and liver fat are independent correlates of cardiovascular and type 2 diabetes risk. The relative contribution of each remains unclear, but implies that both should be considered when developing therapeutic interventions for chronic metabolic disease.

Entities:  

Mesh:

Year:  2008        PMID: 18641726     DOI: 10.1139/H08-059

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  8 in total

Review 1.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

2.  Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT.

Authors:  Cris A Slentz; Lori A Bateman; Leslie H Willis; A Tamlyn Shields; Charles J Tanner; Lucy W Piner; Victoria H Hawk; Michael J Muehlbauer; Greg P Samsa; Rendon C Nelson; Kim M Huffman; Connie W Bales; Joseph A Houmard; William E Kraus
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-16       Impact factor: 4.310

3.  The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial.

Authors:  F M Finucane; S J Sharp; L R Purslow; K Horton; J Horton; D B Savage; S Brage; H Besson; E De Lucia Rolfe; A Sleigh; H J Martin; A Aihie Sayer; C Cooper; U Ekelund; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2010-01-06       Impact factor: 10.122

4.  Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China.

Authors:  Wei-Hui Sun; Ming-Quan Song; Chang-Qing Jiang; Yong-Ning Xin; Jian-Lin Ma; Ying-Xun Liu; Lei Ma; Zhong-Hua Lin; Chang-Yan Li; Ling Liu; Mei Zhang; Lei-Lei Chu; Xiang-Jun Jiang; Qiang Wan; Lin Zhou; Rong Ren; Ling-Fang Meng
Journal:  World J Hepatol       Date:  2012-07-27

5.  Putative factors that may modulate the effect of exercise on liver fat: insights from animal studies.

Authors:  Faidon Magkos
Journal:  J Nutr Metab       Date:  2011-09-08

6.  Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.

Authors:  M Snel; J T Jonker; J Schoones; H Lamb; A de Roos; H Pijl; J W A Smit; A E Meinders; I M Jazet
Journal:  Int J Endocrinol       Date:  2012-05-24       Impact factor: 3.257

7.  Predictive factors for the development or regression of Fatty liver in Japanese adults.

Authors:  Katsuhisa Omagari; Shun-Ichi Morikawa; Seiko Nagaoka; Yukiko Sadakane; Miki Sato; Mizuho Hamasaki; Shigeko Kato; Jun-Ichi Masuda; Masayuki Osabe; Takehiko Kadota; Keisuke Sera
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

8.  Whole-body vibration for patients with nonalcoholic fatty liver disease: a 6-month prospective study.

Authors:  Sechang Oh; Natsumi Oshida; Noriko Someya; Tsuyoshi Maruyama; Tomonori Isobe; Yoshikazu Okamoto; Taeho Kim; Bokun Kim; Junichi Shoda
Journal:  Physiol Rep       Date:  2019-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.